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H I G H L I G H T S
• CB1 receptor inhibits excitatory medial perforant path (MPP) synaptic transmission.
• MPP stimulation triggers CB1-dependent excitatory long-term depression (eCB-eLTD).
• ∼26% of the MPP excitatory terminals contain CB1 receptors.
• eCB-eLTD is group I metabotropic glutamate receptor dependent.
• eCB-eLTD requires 2-arachydonoyl-glycerol (2-AG) synthesis.








A B S T R A C T
The endocannabinoid system modulates synaptic plasticity in the hippocampus, but a link between long-term
synaptic plasticity and the type 1 cannabinoid (CB1) receptor at medial perforant path (MPP) synapses remains
elusive. Here, immuno-electron microscopy in adult mice showed that ∼26% of the excitatory synaptic term-
inals in the middle 1/3 of the dentate molecular layer (DML) contained CB1 receptors, and field excitatory
postsynaptic potentials evoked by MPP stimulation were inhibited by CB1 receptor activation. In addition, MPP
stimulation at 10 Hz for 10min triggered CB1 receptor-dependent excitatory long-term depression (eCB-eLTD) at
MPP synapses of wild-type mice but not on CB1-knockout mice. This eCB-eLTD was group I mGluR-dependent,
required intracellular calcium influx and 2-arachydonoyl-glycerol (2-AG) synthesis but did not depend on N-
methyl-d-aspartate (NMDA) receptors. Overall, these results point to a functional role for CB1 receptors with
eCB-eLTD at DML MPP synapses and further involve these receptors in memory processing within the adult
brain.
1. Introduction
The hippocampus is engaged in the processing of declarative/ex-
plicit memories (Aggleton and Brown, 1999; Eichenbaum, 2000;
Eichenbaum et al., 2012; Eichenbaum and Fortin, 2005), and is a key
component for regulation of cognitive-related behaviors and long-term
memory processing. The endocannabinoid (eCB) system collectively
plays a crucial role in long-term synaptic plasticity in the hippocampus
and throughout the brain, and underlies learning and memory forma-
tion (Azad et al., 2004; Castillo et al., 2012; Chevaleyre and Castillo,
2004; Chiu and Castillo, 2008; Lafourcade et al., 2007; Monday et al.,
2018; Yasuda et al., 2008). Cortical inputs encoding spatial information
(Aggleton and Brown, 1999; Eichenbaum, 2000; Eichenbaum et al.,
2012; Reagh and Yassa, 2014) converge into the dentate gyrus (DG) via
the MPP and lateral (LPP) perforant path (Hjorth-Simonsen, 1972;
Hjorth-Simonsen and Jeune, 1972). The glutamatergic synapses made
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by the MPP with the granule cell dendritic spines in the middle 1/3 of
the DML (Grandes and Streit, 1991) are capable of sustaining long-term
depression (Christie and Abraham, 1994), show paired-pulse depression
at low stimulus intensities (Petersen et al., 2013) and exhibit distinct
forms of eCB-dependent synaptic plasticity (Chávez et al., 2010).
The eCB system is formed by multiple components, including can-
nabinoid receptors (mostly CB1, also CB2 and others), en-
docannabinoids (e.g. 2-AG and anandamide (AEA)), their synthesizing
enzymes (diacylglycerol lipase (DAGL) for 2-AG and N-acyl phospha-
tidylethanolamine phospholipase D for AEA), the degrading enzymes
(monoacylglycerol lipase (MAGL) for 2-AG and fatty acid amide hy-
drolase (FAAH) for AEA) and their transport proteins (Katona and
Freund, 2012; Lutz et al., 2015; Pertwee, 2015; Piomelli, 2003). It is
known that activation of the calcium-selective postsynaptic transient
receptor potential vanilloid 1 (TRPV1) receptor at MPP-granule cell
synapses suppresses excitatory transmission, and brief postsynaptic
depolarizations (1 Hz) induce AEA-mediated TRPV1-LTD in a CB1 re-
ceptor-independent manner (Chávez et al., 2010). These findings are in
support of studies showing there is a high TRPV1 concentration in the
postsynaptic dendritic spines of asymmetric perforant path synapses in
the outer 2/3 of the DML (Puente et al., 2015). Interestingly, post-
synaptic depolarization of DG granule cells can result in eCB release
that suppresses glutamatergic inputs in the innermost 1/3 DML (Chiu
and Castillo, 2008) where the CB1 receptor-containing commissural/
associational glutamatergic synapses converge (Gutiérrez-Rodríguez
et al., 2017; Katona et al., 2006; Uchigashima et al., 2011). However,
the same depolarization protocol does not have any effect on the ex-
citatory synapses of the entorhinal-dentate pathway (Chiu and Castillo,
2008).
Although CB1 receptors are expressed in the excitatory pathways of
the hippocampus (Bonilla-Del Río et al., 2019; Gutiérrez-Rodríguez
et al., 2017; Hu and Mackie, 2015; Katona et al., 2006; Katona and
Freund, 2012; Kawamura et al., 2006; Marsicano and Lutz, 1999;
Monory et al., 2006; Ruehle et al., 2013; Uchigashima et al., 2011), it
still remains unclear what role the CB1 receptor might have in long-
term synaptic plasticity at MPP synapses. In this study, we addressed
this question and discovered eCB-eLTD at the MPP synapses that cor-
relates with the subcellular localization of presynaptic CB1 receptors at
these glutamatergic synapses.
2. Materials and methods
2.1. Animals
Experiments were performed on 11–12 week old male c57BL/6J
mice (Janvier Labs, Le Genest-Saint-Isle, France), global CB1 receptor
knockout (CB1-KO) mice and their wild-type (CB1-WT) littermates. The
animals were housed in pairs of littermates in standard Plexiglas cages
(17 cm×14.3 cm x 36.3 cm) and allowed to habituate to the environ-
ment for at least 1 week before experimental procedures were initiated.
All animals were maintained at approximately 22 °C with a 12:12 h
light:dark cycle (red light on at 9:00 a.m.). Mice had ad libitum access to
food and water throughout all experiments. The protocols for animal
care and use were approved by the Committee of Ethics for Animal
Welfare of the University of the Basque Country (CEEA/M20/2016/
073; CEIAB/2016/074) and were in accordance to the European
Communities Council Directive of 22nd September 2010 (2010/63/EU)
and Spanish regulations (Real Decreto 53/2013, BOE 08-02-2013).
Great efforts were made in order to minimize the number and suffering
of the animals used.
2.2. Slice preparation
Mice were anesthetized with isoflurane (2–4%) and brains were
rapidly removed and placed in a sucrose-based solution at 4 °C that
contained (in mM): 87 NaCl, 75 sucrose, 25 glucose, 7 MgCl2, 2.5 KCl,
0.5 CaCl2 and 1.25 NaH2PO4. Coronal vibratome sections (300 μm
thick, Leica Microsistemas S.L.U.) were collected, recovered at 32–35 °C
before being placed in the recording chamber, and superfused (2ml/
min) with artificial cerebrospinal fluid (aCSF) containing (in mM): 130
NaCl, 11 glucose, 1.2 MgCl2, 2.5 KCl, 2.4 CaCl2, 1.2 NaH2PO4 and 23
NaHCO3, equilibrated with 95% O2/5% CO2. All experiments were
carried out at 32–35 °C. Picrotoxin (PTX; 100 μM, Tocris Bioscience UK)
was added to the aCSF in some experiments to block GABAA receptors.
2.3. Extracellular field recordings
For extracellular field recordings, a glass recording pipette was
filled with aCSF. The stimulation electrode (borosilicate glass capil-
laries, Harvard apparatus UK capillaries 30–0062 GC100T-10) was
placed in the MPP or mossy cell fibers (MCF) and the recording pipette
in the middle 1/3 of the DML. To evoke field excitatory postsynaptic
potential responses (fEPSPs), repetitive control stimuli were delivered
at 0.1 Hz (Stimulus Isolater ISU 165, Cibertec, Spain; controlled by a
Master-8, A.M.P.I.). An Axopatch-200B (Axon Instruments/Molecular
Devices, Union City, CA, USA) was used to record the data filtered at
1–2 kHz, digitized at 5 kHz on a DigiData 1440A interface collected on a
PC using Clampex 10.0 and analyzed using Clampfit 10.0 (all obtained
from Axon Instruments/Molecular Devices, Union City, CA, USA). At
the start of each experiment, an input-output curve was constructed.
Stimulation intensity was selected for baseline measurements that
yielded between 40 and 60% of the maximal amplitude response. To
induce eCB-eLTD of glutamatergic inputs, a low frequency stimulation
(LFS, 10 min at 10 Hz) protocol was applied following recording of a
steady baseline as described previously (Puente et al., 2011).
The magnitude of the fEPSP area for eCB-eLTD was calculated as the
percentage change between baseline area (averaged excitatory re-
sponses for 10min before LFS) and last 10min of stable responses, re-
corded 30min after the end of the LFS. At least 3 mice were used for
each experimental condition. Control mice were always intermixed
with the drug groups. The paired-pulse ratio (PPR) was calculated by
averaging the ratio of the fEPSP initial slopes (P2/P1) of 30 pairs of
pulses (50 msec interpulse interval), where P2 corresponded to fEPSP2
slopes (2nd evoked responses) and P1 to fEPSP1 slopes (1st evoked
responses).
2.4. Data analysis
All values are given as mean ± standard error of the mean (S.E.M)
with p values and sample size (n). Shapiro-Wilk test and Kolmogorov-
Smirnov was used to confirm normality of the data. In general, statis-
tical significance between conditions (baseline versus after drug or
stimulation protocol or both) was tested using parametric (two-tailed
Student's t-test) or non-parametric (Mann-Whitney test) or one-way
analysis of variance (ANOVA) with drug treatment as between group
factor with subsequent post hoc analysis (Duns post test). The sig-
nificance level was set at p < 0.05 for all comparisons. All statistical
tests were performed with GraphPad Prism (GraphPad Prism 5,
GraphPad Software Inc, San Diego, USA; RRID:SCR_002798).
2.5. Electron microscopy
A pre-embedding silver-intensified immunogold method was used
for the localization of the CB1 receptor protein at MPP synapses in the
DML (Gutiérrez-Rodríguez et al., 2017). Adult CB1-WT and CB1-KO
animals (n=3, postnatal day 76) were deeply anesthetized with ke-
tamine/xylazine (80/10mg/kg body weight), perfused through the
heart with phosphate buffered saline (PBS, 0.1M, pH 7.4, 23 °C). They
were then fixed with 250ml of formaldehyde (4%, freshly depolymer-
ized from paraformaldehyde), 0.2% picric acid, and 0.1% glutar-
aldehyde in phosphate buffer (PB; 0.1M, pH 7.4) prepared at 4 °C.
Coronal hippocampal sections cut at 50 μm on a vibratome were
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collected in 0.1 M PB (pH 7.4) at room temperature (RT). Sections were
pre-incubated in a blocking solution of 10% bovine serum albumin
(BSA), 0.02% saponin and 0.1% sodium azide in Tris-HCl buffered
saline (TBS, pH 7.4) for 30min at RT. The sections were then incubated
with goat polyclonal anti-CB1 receptor antibody (2 μg/ml, #CB1-Go-
Af450, Frontier Science Co.;RRID: AB_257130) in 10% BSA/TBS with
0.004% saponin and 0.1% sodium azide, on a shaker for 2 days at 4 °C.
After five washes in 1% BSA/TBS (3× 1min and 2×10min), they
were incubated with 1.4 nm gold-conjugated rabbit anti-goat IgG (Fab’
fragment, 1:100, Nanoprobes Inc., Yaphank, NY, USA) in 1% BSA/TBS
with 0.004% saponin on a shaker for 4 h at RT. After three washes in
1% BSA/TBS (10min each), the tissue was kept in 1% BSA/TBS over-
night at 4 °C, then post-fixed in 1% glutaraldehyde in TBS for 10min
and washed three times in double-distilled water (10min each). Na-
nogold particles were silver-intensified with a HQ Silver kit (Nanop-
robes Inc., Yaphank, NY, USA) for 12min in the dark and then washed
three times in double distilled water (1 min each) and three times in
0.1 M PB (10min each). Immunolabeled sections were osmicated (1%
OsO4 (v/v) in 0.1 M PB, 20min), dehydrated in graded alcohols to
propylene oxide and plastic-embedded in Epon resin 812. Ultrathin
sections (50 nm) were placed on nickel mesh grids, stained with 2.5%
lead citrate for 20min, and then examined with a Philips EM208S
transmission electron microscope. Sections were imaged with a digital
camera (Digital Morada Camera, Olympus) and saved as tif files. Ad-
justments in contrast and brightness were made to the figures using
Adobe Photoshop (Adobe Systems, San Jose, CA, USA; RRID:SCR_
014199).
2.6. Semi-quantification analysis
To ensure an accurate comparison between conditions, the pre-
embedding immunogold method was applied simultaneously to the
hippocampal sections collected from the animals studied (n=3 for
each condition). Labeled sections were examined under a light micro-
scope in order to select portions of the middle 1/3 of the DML with
conspicuous and reproducible CB1 receptor immunolabeling. To avoid
false negatives, only ultra-thin sections within the first 1.5 μm from the
surface of the tissue block were examined. All electron micrographs
were taken at 18,000× magnification and metal particles on mem-
branes were visualized and counted. Positive labeling was considered if
at least one immunogold particle was within 30 nm from the membrane
of the specific compartment under study. Image-J (NIH, USA;
RRID:SCR_003070) was used to measure the membrane length.
Sampling was always carefully and accurately carried out in the same
way for all the animals studied, and experimenters were blinded to the
condition of the subject for CB1 receptor quantification.
A total of 328 excitatory synapses in CB1-WT and 79 excitatory
synapses in CB1-KO mice were measured. Percentages of CB1 receptor
positive profiles, density (particles/μm membrane) of CB1 receptor
immunoparticles in presynaptic terminals and proportion of CB1 re-
ceptor immunoparticles in different compartments versus total CB1
receptor expression in cell membranes were determined and displayed
as mean ± S.E.M. using a statistical software package (GraphPad
Prism, San Diego, USA; RRID:SCR_002798). A normality test
(Kolmogorov-Smirnov) was applied before running further statistical
tests. Data were analyzed using a nonparametric Kruskal-Wallis test.
2.7. Drugs and chemicals
All drugs used in the electrophysiological experiments were dis-
solved in dimethyl sulfoxide (DMSO; Sigma-Aldrich) and added at the
final concentration to the superfusion medium.
3. Results
3.1. CB1 receptor-mediated inhibition of excitatory synaptic transmission at
the MPP-granule cell synapses
Direct activation of CB1 receptors in the DG by the CB1 agonists CP
55.940 (10 μM) or Win-2 (5 μM) in the presence of PTX (100 μM) re-
sulted in a reduction in excitatory synaptic transmission at MPP-granule
cell synapses (Fig. 1A and C). The area of the fEPSP was reduced sig-
nificantly in both conditions (CP 55.940: 83.03 ± 5.67% fEPSP; n = 7;
*p < 0.05 versus baseline; Win-2: 66.55 ± 7.53% fEPSP; n = 6;
***p < 0.001 versus baseline). This depression of the fEPSP was
mediated by CB1 receptors, as it could be prevented by co-perfusion
with the selective CB1 receptor antagonist AM251 (4 μM;
98.47 ± 12.15% fEPSP; n= 4; p > 0.05 versus baseline; Fig. 1B–C).
3.2. Excitatory LTD at dentate MPP-granule cell synapses
We have previously reported that LFS at 10 Hz for 10min induces
eCB-eLTD in the extended amygdala (Puente et al., 2011). In the cur-
rent study, we applied similar stimulation in the presence of PTX and
found that this induced a long-lasting depression at the MPP-granule
cell synapses (16.50 ± 5.75% depression; n = 20; **p < 0.01 versus
Fig. 1. eCB CB1 receptor pharmacology on excitatory synaptic transmission at MPP synapses. (A) Time course plot showing average of fEPSP areas. The CB1
receptor agonists (CP 55.940 10 μM; white circles and Win-2 5 μM; light gray circles) reduce fEPSP (versus baseline). (B) Simultaneous application of CP 55.940
(10 μM; dark gray circles) and a selective CB1 receptor antagonist (AM251; 4 μM) inhibits the synaptic depression observed in A (versus baseline). Black horizontal
bars on top indicate time exposure to drugs. (C) Summary bar histogram comparing experiments performed with CP 55.940 (10 μM), Win-2 (5 μM) and CP
55.940 + AM251 cocktail (10 μM + 4 μM, respectively). Dotted line indicates baseline prior to drug application. Numbers in the bars are individual experiments.
One-way ANOVA (F3,33 = 11.52, ***p < 0.001) and Dunn's Multiple Comparison Test (*p < 0.05; ***p<0.001; p>0.05 versus baseline, respectively). Data
expressed as mean ± S.E.M.
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baseline; Fig. 2A). This LTD could be inhibited by including AM251
(4 μM) in the aCSF but was not by the NMDA receptor antagonist D-APV
(50 μM; Fig. 2A and E). When these same stimuli were applied in re-
cordings made from global CB1-KO mice, the 10 Hz stimuli failed to
induce eCB-eLTD (Fig. 2B and E). Rather, in these mice the 10 Hz sti-
mulation produced a slight potentiation (13.14 ± 4.81% potentiation;
n = 8; ***p < 0.01 versus baseline; Fig. 2B) that was reduced to
baseline levels by perfusion with D-APV (50 μM; 1.74 ± 3.72% po-
tentiation; n=8; p > 0.05 versus baseline; p > 0.05 versus po-
tentiation value from CB1-KO; Fig. 2B and E).
In contrast to the results obtained in the DML, application of the
10 Hz stimulation at MCF synapses did not induce eCB-eLTD
(11.82 ± 5.11% potentiation; n = 11; **p < 0.01 versus MPP eCB-
eLTD; Fig. 2D) as previously shown by Chiu and Castillo (2008). The
small potentiation that was observed at these synapses
(11.82 ± 5.11% potentiation; *p < 0.05 versus baseline; Fig. 2D) was
reduced to baseline levels by the perfusion with D-APV (3.07 ± 4.15%
potentiation; n=11; p > 0.05 versus baseline; p > 0.05 versus po-
tentiation value from MCF; Fig. 2D and E). Together, these results de-
monstrate that the 10 Hz stimuli are able to induce eCB-eLTD not
previously reported at MPP-granule cell synapses.
3.3. eCB-eLTD mechanisms at MPP-granule cell synapses
To determine if eCB-eLTD has a presynaptic or postsynaptic loci we
examined the PPR prior to, and following, the induction of eCB-eLTD.
We found that eCB-eLTD involves the suppression of presynaptic
transmitter release, since there was a significant increase in the PPR
following the application of the 10 Hz stimuli (1.04 + 0.04; n = 11;
*p < 0.05 versus Pre-LFS; Fig. 2C).
The group I mGluR agonist 3.5-DHPG produced a significant de-
crease in the fEPSP of MPP in sham mice (Fig. 3A). In addition, 3.5-
DHPG has previously been reported to induce LTD at CA1 synapses
(Huber et al., 1998), but it is not clear whether the MPP input to the DG
is capable of sustaining this form of LTD. To explore the contribution of
the mGluR/phospholipase C (PLC) pathway to eCB-eLTD, the applica-
tion of 3.5-DHPG (50 μM) occluded the subsequent induction of eCB-
eLTD (10.54 ± 9.48% potentiation; n = 11; *p < 0.05 versus MPP
eCB-eLTD; p > 0.05 versus baseline; Fig. 3B and D). In addition, eCB-
eLTD could also be inhibited by administration of either the mGluR5
antagonist MPEP (10 μM; 14.20 ± 10.54% potentiation; n = 13;
*p < 0.05 versus MPP eCB-eLTD; p > 0.05 versus baseline; Fig. 3C–D)
or the mGluR1 antagonist CPCCoEt (50 μM; 9.48 ± 6.69% potentia-
tion; n = 10; **p < 0.01 versus MPP eCB-eLTD; p > 0.05 versus
baseline; Fig. 3C–D). Endocannabinoids have been shown to suppress
Fig. 2. eCB-dependent LTD at MPP synapses. (A) LFS (10 Hz for 10min) at the time marked by the X-axis break triggers eCB-eLTD at MPP synapses (white circles;
Student's t-test, two tailed, t38= 2.89; **p < 0.01 versus baseline). While AM251 (4 μM) inhibits eCB-eLTD (black circles; Student's t-test, two tailed, t14= 1.39;
p > 0.05 versus baseline), the NMDA receptor antagonist D-APV (50 μM) is ineffective (gray circles; Student's t-test, two tailed, t16= 2.68; *p < 0.05 vs. baseline).
(B) eCB-eLTD is induced in CB1-WT littermate mice (white circles; Mann Whitney test; **p < 0.01 versus baseline) but not in CB1-KO mice (black circles; Mann
Whitney test; ***p < 0.001 versus baseline). The slight but significant LTP in CB1-KO is suppressed by D-APV (50 μM; gray circles; Mann Whitney test; p > 0.05
versus baseline). (C) PPR was calculated from the slopes of 30 sweeps (i.e. 10 min before and 20min after stimulation protocol). PPR is augmented after LFS (Post-
LFS). Student's t-test, two tailed, t20= 2.63; *p < 0.05 versus Pre-LFS. Numbers in the bars are individual experiments. (D) LFS (10 Hz for 10min) induces a slight
LTP at MCF synapses in the inner 1/3 of the DML (black circles; Student's t-test, two tailed, t20= 2.31; *p < 0.05 versus baseline) which is inhibited by D-APV
(50 μM; grey circles; Student's t-test, two tailed, t20= 0.73; p > 0.05 versus baseline). (E) Summary bar histogram of the experiments performed: c57, AM251
(4 μM), D-APV (50 μM), CB1-WT, CB1-KO and CB1-KO + D-APV (50 μM) in MPP, c57 and D-APV (50 μM) in MCF. One-way ANOVA (F8,84 = 5.37, ***p < 0.001)
and Bonferroni's Multiple Comparison Test (p > 0.05; *p < 0.05; **p < 0.01 versus c57). Numbers in the bars are individual experiments. Data are expressed as
mean ± S.E.M.
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neurotransmitter release when they are released following a depolar-
ization that increases intracellular calcium levels (Brenowitz and
Regehr, 2003) or by activation of the G-protein coupled mGluR/PLC
pathway to produce diacylglycerol (DAG, Yoshida et al., 2006). We
found that the inclusion of thapsigargin (2 μM), a sarco/endoplasmic
reticulum Ca2+-ATPase pump blocker in the aCSF was able to block
eCB-eLTD (17.88 ± 7.35% potentiation; n=12; **p < 0.01 versus
MPP eCB-eLTD; Fig. 3D) suggesting a role for intracellular calcium in
eCB-eLTD. However, calcium influx from L-type voltage-gated calcium
channels is not involved in this eCB-eLTD, since the inclusion of ni-
modipine (1 μM) in the aCSF did not block eCB-eLTD (25.65 ± 10.20%
depression; n= 8; p > 0.05 versus MPP eCB-eLTD; Fig. 3D). Together,
these data indicate that the activation of group I mGluRs and in-
tracellular calcium release are necessary for eCB-eLTD at MPP-granule
cell synapses.
The 10 Hz stimuli were also applied in the presence of the DAGL
inhibitors tetrahydrolipstatin (THL, 10 μM) or RHC-80267 (100 μM). In
both conditions, eCB-eLTD was completely abolished (THL:
14.17 ± 7.31% potentiation; n = 7; **p < 0.01 versus MPP eCB-
eLTD; RHC-80267: 11.12 ± 6.16% potentiation; n = 4; *p < 0.05
versus MPP eCB-eLTD; Fig. 4A and C). Also, the PLC inhibitor U73122
(5 μM) blocked eCB-eLTD (18.56 ± 6.15% potentiation; n = 6;
**p < 0.01 versus MPP eCB-eLTD; Fig. 4C). These data suggest that
PLC activity is required for 2-AG synthesis and the induction of eCB-
eLTD. Furthermore, the MAGL inhibitor JZL184 (50 μM) also blocked
the eCB-eLTD (6.93 ± 3.54% potentiation; n = 12; **p < 0.01 versus
MPP eCB-eLTD; Fig. 4C) suggesting that 2-AG regulation may be a
limiting factor for eCB-eLTD induction, since JZL184 reduced the fEPSP
area by its own (75.74% ± 14.13% of depression; n= 6. Data not
shown). Consequently, CB1 receptor desensitization caused by a high 2-
AG concentration and the long JZL184 incubation time before record-
ings (Fig. 4C) could be responsible for the eCB-eLTD blockade. In this
line, previous studies have shown that a long-term increase in 2-AG
elicits CB1 receptor desensitization (Chanda et al., 2010; Schlosburg
et al., 2010). By contrast, eCB-eLTD was unaffected by the potent and
selective FAAH inhibitor URB 597 (2 μM; 18.14 ± 8.52% depression;
n=10; p > 0.05 versus MPP eCB-eLTD; *p < 0.05 versus baseline;
Fig. 4B–C) indicating that AEA is not involved in the eCB-eLTD at the
MPP-granule cell synapses.
3.4. Subcellular localization of CB1 receptors at MPP terminals in the DG
CB1 receptor immunogold particles in the middle 1/3 of the DML
were localized to inhibitory and excitatory axon terminals forming sy-
napses with dendrites and dendritic spines, respectively, and several
other cell compartments (Fig. 5). The proportion of the total CB1 re-
ceptor gold particle distribution was determined in excitatory terminals
(12.03 ± 0.91%), inhibitory terminals (54.90 ± 2.18%), mitochon-
dria (8.72 ± 0.22%), dendrites (10.39 ± 1.90%) and other mem-
branes (13.94 ± 1.03%; Fig. 5D). Furthermore, 26.31 ± 1.19% of the
excitatory terminals were CB1 receptor-positive with a density of
0.64 ± 0.04 CB1 receptor particles/μm. CB1 receptor immunolabeling
was absent in the CB1-KO mice (***p < 0.001 versus WT; Fig. 5 E-G).
Fig. 3. Activation of group I mGluRs and calcium from intracellular stores are required for eCB-eLTD at MPP synapses. The average of the fEPSP areas is
shown. (A) The group I mGluR agonist 3.5-DHPG reduces fEPSPs (white circles; Mann Whitney test; *p < 0.05 versus baseline). (B) eCB-eLTD elicited by LFS (white
circles) is prevented by co-application of 3.5-DHPG (50 μM; black circles; Student's t-test, two tailed, t20= 0.74; p > 0.05 versus baseline). (C) The mGluR5
antagonist MPEP (10 μm; grey circles; Mann Whitney test; p > 0.05 versus baseline) and the mGluR1 antagonist, CPCCoEt (50 μM; black circles; Mann Whitney test;
p > 0.05 versus baseline), inhibit eCB-eLTD (white circles; Student's t-test, two tailed, t38= 2.89; **p < 0.01 versus baseline). (D) Summary bar histogram of the
experiments performed: c57, 3.5-DHPG (50 μM), MPEP (10 μm), CPCCoEt (50 μM), nimodipine (1 μM), thapsigargin (2 μM,>1 h). Mann Whitney test; p > 0.05;
*p < 0.05; **p < 0.01 versus c57. Numbers in the bars are individual experiments. Data expressed as mean ± S.E.M.
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4. Discussion
This study reveals the existence of CB1 receptor-dependent ex-
citatory LTD at the MPP synapses in the DG of adult c57BL/6J male
mice that requires postsynaptic activation of group I mGluRs, calcium
release from intracellular stores, and 2-AG synthesis acting on pre-
synaptic CB1 receptors localized at glutamatergic presynaptic terminals
of the MPP.
4.1. Mechanisms underlying the eCB-eLTD at MPP-granule cell synapses
We found a CB1 receptor-dependent inhibition of MPP-granule cell
excitatory synaptic transmission. In addition, a LFS protocol (10 Hz for
10min) that has previously been used to consistently induce eCB-
Fig. 4. 2-AG is necessary for eCB-eLTD at MPP synapses. The average of the fEPSP area is shown. (A) eCB-eLTD (white circles) is abolished by the DAGL inhibitors
THL (10 μM; grey circles; Student's t-test, two tailed, t12= 1.93; p > 0.05 versus baseline) and RHC-80267 (100 μM; black circles: Mann Whitney test; p > 0.05
versus baseline, respectively). (B) The FAAH inhibitor URB 597 (2 μM,>20min; black circles) is ineffective at eCB-eLTD (Student's t-test, two tailed, t18= 2.12;
*p < 0.05 versus baseline). (C) Summary bar histogram of the experiments performed: c57, THL (10 μM), RHC-80267 (100 μM), U73122 (5 μM,>1 h), JZL184
(50 μM,>1 h) and URB 597 (2 μM,>20min). Mann Whitney test; p > 0.05; *p < 0.05; **p < 0.01 versus c57. Numbers in the bars are individual experiments.
Data expressed as mean ± S.E.M.
Fig. 5. Immunoelectron localization of CB1 receptors in the middle 1/3 of the DML. (A) Reconstruction of the whole DML and granule cell layer (GCL)
indicating where images shown in B and C are from. Scale bar= 10 μm. (B, C) CB1 receptor immunogold labeling (arrows) is observed on presynaptic excitatory
terminals (ExT) forming asymmetric synapses (arrowheads) with dendritic spines (sp). Scale bars= 0.5 μm. (D) Proportion of CB1 receptor labeling in different
compartments normalized to the total CB1 receptor signal. (E) Percentage of CB1 receptor-immunopositive excitatory terminals in WT and CB1-KO mice. Student's t-
test, two tailed, t36= 5.56; ***p < 0.001 versus WT. The number of synaptic terminals analyzed is in parentheses on the top of each column. (F) No CB1 receptor
immunolabeling is seen in CB1-KO mice. (G) CB1 receptor density (particles/μm) in CB1 receptor positive excitatory terminals. Data expressed as mean ± S.E.M.
Scale bars= 0.5 μm.
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dependent LTD in other brain regions (Lafourcade et al., 2007; Puente
et al., 2011), elicited a eCB-eLTD at MPP synapses. We also observed
that the magnitude of eCB-eLTD was unaffected by the NMDA receptor
antagonist D-APV suggesting that NMDA receptors were not involved in
the eCB-eLTD despite the fact that eCB-eLTD may require NMDA re-
ceptor activity at other synapses (Bender et al., 2006; Sjöström et al.,
2003). Intriguingly, the slight potentiation observed in CB1-KO mice
after LFS could be triggered by the increase in glutamate release and
NMDA receptor activation (Errington et al., 1987) since that potentia-
tion disappeared after bath perfusion of D-APV. CB1 receptors are
highly expressed in the innermost 1/3 of the DML which receives ex-
citatory inputs from hilar mossy cells (Gutiérrez-Rodríguez et al., 2017;
Katona et al., 2006; Kawamura et al., 2006; Monory et al., 2006).
However, consistent with a prior report (Chiu and Castillo, 2008), the
stimulation protocol applied in our study was unable to induce eCB-LTD
at mossy cell-granule cell synapses, but rather induced a small LTP that
was inhibited by D-APV.
The stimulation paradigm could be a critical factor for the eCB-eLTD
induction at the MPP-granule cell synapses. Furthermore, a TRPV1-
dependent LTD at these same synapses was shown to require mGluR5
activation, but not mGluR1, and involved postsynaptic AMPA receptor
internalization (Chávez et al., 2010). In our study, LFS of MPP inputs
activated both mGluR1 and mGluR5 leading to an increase in in-
tracellular calcium released from the sarco/endoplasmic reticulum.
TRPV1-LTD could also be induced by stimulation at 10 Hz for 10min in
the bed nucleus of the stria terminalis (BNST) which was mediated by
postsynaptic mGluR5-dependent release of AEA acting on postsynaptic
TRPV1 receptors, and strongly inhibited by depletion of intracellular
calcium stores (Puente et al., 2011). We found that the eCB-eLTD at
MPP synapses was 2-AG dependent and activates CB1 receptors dis-
tributed on presynaptic excitatory terminals in the middle 1/3 of the
DML. In the BNST, however, dendritic L-type calcium channels and the
subsequent release of 2-AG acting on presynaptic CB1 receptors trig-
gered retrograde short-term depression (Puente et al., 2011).
The different kinetics of recovery after LFS following MPEP and
CPCCoEt suggest that mGluR5 and mGluR1 contribute differentially to
the eCB-eLTD shown at the MPP-granule cell synapses. That is, while
MPEP has an effect on both the induction and late phase, CPCCOEt only
affects the late phase of this form of plasticity. Our results demonstrate
that both mGluR5 and mGluR1 activation is critically required for
persistent eCB-LTD at the MPP-granule cell synapses. However, only
mGluR5, and not mGluR1, is required for the initial depression.
Previous studies in the CA1 hippocampus have shown that differences
between both group I mGluR subtypes have distinct effects on synaptic
plasticity and memory processes (Neyman and Manahan-Vaughan,
2008). Mechanistically, the activation of mGluR1 causes an in-
tracellular calcium rise, neuronal depolarization and increase in the
frequency of spontaneous inhibitory postsynaptic potentials
(Mannaioni et al., 2001). However, mGluR5 activation leads to the
suppression of calcium-activated potassium currents (IAHP) and the
potentiation of NdNMDA receptor currents (Attucci et al., 2001; Jia
et al., 1998; Mannaioni et al., 2001).
The variability observed among studies could be due to several
critical factors like mouse age (PND 74–80), temperature of the in vitro
experiments (32–35 °C) and/or the stimulation paradigm. Significantly,
the eCB-LTD can be induced at either presynaptic (our work) or post-
synaptic loci (Chávez et al., 2010) of the MPP-granule cell synapses
depending on the stimulation, recruiting either presynaptic CB1 re-
ceptors or postsynaptic TRPV1 and mobilizing 2-AG or AEA, respec-
tively. Together, our findings further suggest that the precise sub-
cellular localization of the eCB components in specific cell types and
synapses are key players for the induction of diverse forms of synaptic
plasticity through distinct signaling mechanisms (Castillo et al., 2012;
Puente et al., 2011).
4.2. Functional context of the eCB-eLTD at MPP-granule cell synapses
Brain functions regulated by the eCB system rely on its distribution
in cerebral tissue (Busquets-Garcia et al., 2018; Castillo et al., 2012; Hu
and Mackie, 2015; Katona and Freund, 2012). The hippocampus is re-
quired for declarative/episodic memory and is involved in spatial and
context-dependent learning (Eichenbaum et al., 2012). Inputs from the
postrhinal cortex convey spatial information to the dorsolateral medial
entorhinal cortex that projects to the dorsal hippocampus through the
MPP (Fyhn et al., 2004; Hargreaves et al., 2005). On the other hand, the
perirhinal cortex projects to the lateral entorhinal cortex which gives
rise to the LPP (Burwell, 2000). The LPP pathway transmits non-spatial
information, and, together with information about spatial clues for-
warded by the MPP into the DG, representations for object-place or
event-place scenarios are thought to be built (Gaffan, 1998; Hargreaves
et al., 2005; Suzuki et al., 1997). At the same time, signal integration by
granule cells related to environment or context is under control of hilar
mossy cells which are critical in the learning of information sequences
(Lisman et al., 2005). The mossy cells receive glutamatergic granule
mossy fiber collaterals, and in turn send commissural/associational fi-
bers that travel long distances giving innervation to multiple dentate
granule cells forming mossy-granule cell synapses (Amaral and Witter,
1989; Scharfman and Myers, 2013). The glutamatergic synapses of the
three excitatory pathways targeting the dentate granule cells contain
CB1 receptors (Gutiérrez-Rodríguez et al., 2017; Katona et al., 2006;
Katona and Freund, 2012; Kawamura et al., 2006; Marsicano and Lutz,
1999; Monory et al., 2006; Uchigashima et al., 2011; Wang et al., 2016)
and display different forms of eCB dependent-synaptic plasticity
(Chávez et al., 2010; Chiu and Castillo, 2008; Wang et al., 2018, 2016)
which correlate with the distinct information processed by each
pathway Table 1.
As previously shown in single BNST neurons (Puente et al., 2011),
either the 2-AG and CB1 receptor-dependent eLTD herewith described,
or the AEA and TRPV1-dependent eLTD at the MPP synapses (Chávez
et al., 2010) might each be switched on by distinct patterns of neural
activity conveying spatial information. At the same time, high fre-
quency stimulation of the LPP in the outer 1/3 of the DML leads to 2-AG
production and CB1 receptor-dependent eLTP at these LPP synapses
which have been associated with memories related to odor dis-
crimination, and semantic information and representation (Wang et al.,
2018, 2016).
Altogether, the spatial and non-spatial information transmitted by
granule cells to CA3 pyramidal neurons that provides sequence learning
and sequence prediction (Hunt et al., 2013) would involve perforant
path inputs and different forms of cannabinoid-dependent plasticity
recruited upon the type of information processed, all being modulated
by mossy cell activity. Learning and memory processes that involve the
hippocampus can be affected by some pathological conditions. For in-
stance, impaired recognition, spatial, and associative memories can be
observed in the adult brain after high ethanol exposure (binge drinking)
during adolescence (Rico-Barrio et al., 2018). This also correlates with a
decrease in CB1 receptor expression in astrocytes (Bonilla-Del Río et al.,
2019), as well as with changes in CB1 receptor expression at the per-
forant path synapses (Peñasco et al., 2015). Interestingly, the memory
impairment observed after adolescent binge drinking is recovered in
adults exposed to enriched environmental conditions (Rico-Barrio et al.,
2018). It is plausible that changes in different forms of CB1 receptor-
dependent plasticity in the DG underlie the memory deficits observed in
adults after adolescent binge drinking, as well as in the distortion of
space perception experienced as a psychoactive effect of cannabis use.
5. Conclusions
Field excitatory postsynaptic potentials evoked by MPP stimulation
in the DML are inhibited upon CB1 receptor activation. Second, low
frequency stimulation (10min, 10 Hz) of the MPP of adult c57BL/6J
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male mice triggers eCB-eLTD at the MPP-granule cell synapses that is
absent in CB1-KO mice. Third, the eCB-eLTD is group I mGluR-depen-
dent and requires intracellular calcium influx and 2-AG synthesis. This
eCB-eLTD at the MPP-granule cell synapses herewith described for the
first time widens the knowledge on the role of CB1 receptors in different
forms of synaptic plasticity in the brain.
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